Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/4/2017
SIETES contiene 91761 citas

 
 
 1 a 20 de 6702 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Schick A, Miller KL, Lanthier M, Pan GD, Nardinelli C. Evaluation of pre-marketing factors to predict post-marketing boxed warnings and safety withdrawals. Drug Saf 2017:24 de marzo. [Ref.ID 101505]
2. Cita con resumen
Anónimo. Litigation is new tactic in opioid crisis. DIA Daily 2017:1. [Ref.ID 101500]
5. Cita con resumen
Anónimo. FDA pushes back on Trump’s claims of slow drug reviews. DIA Daily 2017:8. [Ref.ID 101452]
6. Cita con resumen
Nardone B, Majewski S, Kim AS, Kiguradze T, Martínez-Escala EM, Friedland R, Amin A, Laumann AE, Edwards BJ, Rademaker AW, Martini MC, West DP. Melanoma and non-melanoma skin cancer associated with angiotensin-converting-enzyme inhibitors, angiotensin-receptor blockers and thiazides: a matched cohort study. Drug Saf 2017;40:249-55. [Ref.ID 101451]
7. Cita con resumen
9. Cita con resumen
Anónimo. Pembrolizumab (Keytruda) for first-line treatment of metastatic NSCLC. Med Lett Drugs Ther 2017;59:22-3. [Ref.ID 101421]
10. Cita con resumen
Anónimo. Lixisenatide for type 2 diabetes. Med Lett Drugs Ther 2017;59:19-21. [Ref.ID 101420]
11.Enlace a cita original Cita con resumen
Maust DT, Gerlach LB, Gibson A, Kales HC, Blow FC, Olfson M. Trends in central nervous system–active polypharmacy among older adults seen in outpatient care in the United States. JAMA Intern Med 2017:13 de febrero. [Ref.ID 101408]
13. Cita con resumen
14. Cita con resumen
Anónimo. FDA approves fewest new drugs last year since 2010. DIA Daily 2017:2. [Ref.ID 101018]
15. Cita con resumen
Anónimo. Death toll from drug overdoses “nearly tripled” from 1999 to 2014. DIA Daily 2016:5. [Ref.ID 101010]
16. Cita con resumen
Anónimo. Global spending on prescription drugs to hit $1.5 trillion by 2021. DIA Daily 2016:1. [Ref.ID 100994]
17.Tiene citas relacionadas Cita con resumen
Kessler C, Ward MJ, McNaughton CD. Reducing adverse drug events: the need to rethink outpatient prescribing. JAMA 2016;316:2092-3. [Ref.ID 100974]
18.Tiene citas relacionadas Cita con resumen
Shehab N, Lovegrove MC, Geller AI, Rose KO, Weidle NJ, Budnitz DS. US emergency department visits for outpatient adverse drug events, 2013-1014. JAMA 2016;316:2115-25. [Ref.ID 100973]
19. Cita con resumen
Anónimo. FDA declines to approve bladder cancer treatment. DIA Daily 2016:3. [Ref.ID 100964]
20. Cita con resumen
Anónimo. Various states approve recreational, medical marijuana use. DIA Daily 2016:7. [Ref.ID 100907]
Seleccionar todas
 
 1 a 20 de 6702 siguiente >>